Skip to content

The ATLANTIS Trial

Aquatic Therapy to Lower Adverse and Negative Effects of Venous Thrombosis and InSufficiency

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02553720
Acronym
ATLANTIS
Enrollment
181
Registered
2015-09-18
Start date
2015-09-30
Completion date
2018-01-31
Last updated
2020-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Venous Hypertension Due to Deep Vein Thrombosis, Venous Reflux

Keywords

Post thrombotic syndrome, Chronic venous insufficiency

Brief summary

The purpose of this study is to test whether addition of aquatic exercise to conventional treatment helps reduce the adverse outcomes of chronic venous insufficiency including CVI resulting from venous thrombosis.

Detailed description

Post-thrombotic syndrome (PTS) develops in approximately 25-60% of patients with acute lower extremity deep venous thrombosis (DVT) depending on severity, chronicity, anatomic level of involvement and efficacy of anticoagulation.The frequency increases with occlusive iliac venous thrombosis. PTS results in significant morbidity and a staggering toll on health careresources . PTS is reduced by early percutaneous endovenous intervention and administration of new oral anticoagulants. There are conflicting results on the efficacy of exercise . In general, exercise has been useful in activation of the muscle pump and improvement of symptoms. There are no data about exercise in a swimming pool. Both walking in water or swimming reduce the effect of joint contact and therefore pain which is particularly useful in patients with arthritis or heavyweight. Furthermore with less effect of gravity, absorption of dependent edema would be faster. Dry skin becomes hydrated and the chlorine of water can exert antiseptic properties. There are no data on the role of aquatic activity in the reduction of measures of venous insufficiency.The purpose of this study is to assess whether encouragement of patients to perform aquatic activity in addition to baseline treatment would positively impact chronic venous insufficiency.

Interventions

The patients will be instructed to perform walking or swimming for 15 minutes, 3 times a week for 3 months in a swimming pool in addition to conventional management

OTHERaquatic activity plus conventional management

walking in water or swimming for 15 minutes, 3 times a week for 3 months in a swimming pool in addition to conventional management

Sponsors

A.T. Still University of Health Sciences
CollaboratorOTHER
Arizona Cardiovascular Consultants
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

A total of 201 patients were randomized with 100 to the Aquatic Group and 101 to the Control Group. At 24 months, 91 patients had completion of evaluation in the Aquatic Group and 90 patients in the Control Group.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

age\>18 years; a Villalta score of ˃5 or a modified Venous Clinical Severity Score (VCSS) of ˃5 plus ongoing symptoms of ˃3 months despite receiving conservative management (minimum of 2 of the following: compression stockings, leg elevation, physical activity on land and use of non-steroidal anti-inflammatory drugs where appropriate, for the preceding 3 months).

Exclusion criteria

consisted of unwillingness or inability to use or no access to a swimming pool; open ulceration; planned intervention for arterial or superficial venous reflux, deep venous thrombosis (DVT), venous stenosis, pelvic congestion syndrome, within the first 3 months of enrolment; or using a swimming pool on a regular basis.

Design outcomes

Primary

MeasureTime frameDescription
4 point drop in modified VCSS3 months and 2 yearsModified VCSS score at baseline, 3 m and 2 years.

Secondary

MeasureTime frameDescription
Mortality2 yearsDevelopment of death at follow up.
VEINES QOL/Sym3months and 2 yearschanges of time velocity integral of the spectral Doppler waveform.
Recurrent venous thromboembolic disease3 months and 2 yearsMeasured objectively by venous duplex or CT angiography or V/Q scan if indicated
Viallta Score3 months and 2 yearsChanges in the Vllalta scoring system
SF 36 questionnaire-PHC3 months and 2 yearsChanges in score before and after intervention
Thigh and leg circumference3 months and 2 yearsChanges in circumference before and after intervention
Subjective Index alteration3 months and 2 yearsChanges in score before and after intervention
Modified Venous Clinical Severity Score3months and 2 yearsChanges in absolute scores before and after intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026